91,599 (84.4%) of the trial participants had T2D
Methods Trial Designs The designs of the PIONEER 35, 7 and 8 trials have been reported previously and are summarised in Table 1 [7,8,9,10,11]
Some of the most common side effects (but not extremely frequent) are: fatigue or low energy difficulty sleeping nervousness and anxiety headache nausea or vomiting joint and muscle pain stomach cramps or pain Additional side effects include: loss of appetite diarrhea or constipation increased energy increased thirst dizziness skin rash sexual problems in males chills runny nose irritability or feeling down These symptoms may subside after the body adjusts to the medication
However, if youll be away from your medication for more than 7 days, it is crucial to consult with your provider before resuming treatment
Possible Side Effects La ipamorelina es generalmente bien tolerada en estudios preclnicos y en investigaciones humanas limitadas, presentando un perfil de seguridad favorable en comparacin con pptidos liberadores de la hormona del crecimiento anteriores
GLP-1 Insurance Coverage Landscape GLP-1 drugs coverage depends on payer type (commercial/employer plans, Medicare, Medicaid) and on the indication (diabetes vs obesity)
